Seizures in patients with pork tapeworm caused by Substance P

February 9, 2012 in Diseases, Conditions, Syndromes

A neuropeptide called Substance P is the cause of seizures in patients with brains infected by the pork tapeworm (Taenia solium), said Baylor College of Medicine researchers in a report that appears online in the open access journal PLoS Pathogens.

"Neurocysticercosis or the tapeworm in the , is the major cause of acquired seizures," said Dr. Prema Robinson, assistant professor of medicine – infectious diseases, and corresponding author of the report. "It is particularly important to understand the source of these seizures in order to develop ways to treat and prevent them."

Substance P is a neuropeptide (a small protein-like molecule involved in neuron-to-neuron communication.) It is produced by neurons, endothelial cells (the cells that line blood vessels) and cells involved in host defense. Discovered in the 1930s, it has long been recognized as a pain transmitter. However, in recent years, it has also been found to play a role in many other functions.

Robinson realized that Substance P is involved in inflammation and wondered if it might be involved in seizure activity.

Robinson and her colleagues – including one from Tufts Medical Center in Boston – found Substance P in autopsies of the brains of patients who had the tapeworm infection. They did not find Substance P in uninfected brains.

"As long as the parasite is alive, nothing happens," said Robinson. However, once the worm dies, the body responds with chemicals that recruit immune system cells to the site of infection, causing inflammation. Her studies showed that the cells that produce Substance P are found mainly in areas of inflammation near the dead worms.

Animals injected with Substance P alone or with extracts from the areas of inflammation (granulomas) near the worms in infected mice suffered severe seizures, she said.

When the rodents received the drug that blocks the Substance P receptor, they did not have seizures, she said.

In addition, mice that lacked the Substance P receptor did not have seizures even when injected with the extracts of granulomas from infected mice. In addition, granuloma extracts from mice that lacked the cells that make Substance P did not induce seizures.

These findings have implications for people, who often suffer seizures during treatment for the tapeworm infection, she said. As the worms die, inflammatory rush to the scene and the seizures begin. There are medications known to block the receptor for Substance P. These medications may prove to be the most effective means of treating and preventing seizures in these patients.

Robinson plans to look at the role Substance P may play in other diseases associated with such as cancer and tuberculosis.

Provided by Baylor College of Medicine search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Little evidence for prediction rules for low back pain

(HealthDay)—Few randomized clinical trials have been done to assess clinical prediction rules for patients with lower back pain, and the trials that have been done are of low quality and do not provide ...

Diseases, Conditions, Syndromes created 12 hours ago | popularity not rated yet | comments 0 | with audio podcast

New malaria test kit gives a boost to elimination efforts worldwide

A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to ...

Diseases, Conditions, Syndromes created 16 hours ago | popularity not rated yet | comments 0

WHO says single yellow fever shot is enough

(AP)—The World Health Organization says a yellow fever booster vaccination given 10 years after the initial shot isn't necessary.

Diseases, Conditions, Syndromes created 17 hours ago | popularity not rated yet | comments 0

23 dead in initiation rites in South Africa

(AP)—Twenty-three youths have died in the past nine days at initiation ceremonies that include circumcisions and survival tests, South African police said Friday.

Diseases, Conditions, Syndromes created 17 hours ago | popularity 5 / 5 (1) | comments 2

Expert questions US public health agency advice on influenza vaccines

The United States government public health agency, the CDC, pledges "To base all public health decisions on the highest quality scientific data, openly and objectively derived." But Peter Doshi, a postdoctoral fellow at Johns ...

Diseases, Conditions, Syndromes created May 16, 2013 | popularity not rated yet | comments 0


AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

Study identifies new approach to improving treatment for MS and other conditions

(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...